Pazopanib Shows Promise for Children, Adults with Soft Tissue Sarcomas

For children and adults with advanced soft tissue sarcoma, adding pazopanib (Votrient) to chemotherapy and radiation before surgery may be a promising treatment option, early results from a clinical trial suggest.

from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/3m6hNVG